A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-γ and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor

This publication has 36 references indexed in Scilit:

• Efficacy of Two Alternate Vaccines Based onPlasmodium falciparumMerozoite Surface Protein 1 in anAotusChallenge Trial
  Infection and Immunity, 2001
• Protection ofAotusMonkeys byPlasmodium falciparumEBA‐175 Region II DNA Prime–Protein Boost Immunization Regimen
  The Journal of Infectious Diseases, 2001
• Immunogenicity and Efficacy inAotusMonkeys of Four RecombinantPlasmodium falciparumVaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1
  Infection and Immunity, 2000
• Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoid
  Vaccine, 1999
• An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi
  The Journal of Infectious Diseases, 1997
• Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
  Immunity, 1995
• Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.
  The Journal of Experimental Medicine, 1994
• Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP119) variants secreted from Saccharomyces cerevisiae
  Molecular and Biochemical Parasitology, 1994
• Immunization against malaria with a recombinant protein
  Parasite Immunology, 1994
• Immunization against blood-stage rodent malaria using purified parasite antigens
  Nature, 1981